Browsing Tag
Melbourne
67 posts
REA Group (ASX: REA) shares jump as Q3 FY2026 result lifts cost guidance and confirms residential recovery
REA Group fell 9.6% on H1 results in February. Today's Q3 print rewrites that thesis. Listing volumes are back, yield is at 14%, costs are being held.
Textron Inc. (NYSE: TXT) strengthens Asia-Pacific support with Essendon Fields expansion
APAC aircraft demand is rising faster than service capacity. Textron Aviation’s Melbourne bet could reshape regional support economics.
Pinnacle Investment Management (ASX: PNI) share price jumps 5% after Pacific Asset Management completion
Pinnacle just closed the $419m PAM deal and the stock bounced 5%. Affiliate FUM hits $202.5bn. Performance fees are the next test in July.
Persistent Systems (NSE: PERSISTENT) grows at five times Infosys’s guided pace in FY26 as AI deal wins accelerate
Persistent Systems posts $1.65B FY26 revenue with 17.4% growth and 15.6% EBIT margin. Read what the 24th consecutive growth quarter signals for Indian IT. →
Atomos (ASX: AMS) bets on new product cycle and NAB Show 2026 to lock in its turnaround
Atomos (ASX: AMS) returned to profit in H1 FY2026 with 28% revenue growth. Here is the retail investor roadmap for the next phase of its turnaround.
Algorae Pharmaceuticals (ASX: 1AI) raises A$4m to fund dual commercial and AI drug discovery growth strategy
Algorae Pharmaceuticals (ASX: 1AI) raises A$3.99m to scale AlgoraeRx commercial portfolio and advance AlgoraeOS AI drug pipeline. Read the full strategic analysis.
Catapult Sports (ASX: CAT) posts record 27-28% ACV growth in FY26 trading update as dual acquisitions reshape the sports analytics platform
Catapult Sports (ASX: CAT) records 27-28% ACV growth and 50% EBITDA jump in FY26. Read what the dual acquisitions mean for the sports analytics race. Read more.
Careteq (ASX: CTQ) raises A$2.2m at steep discount to fund acquisitions and clear debt as stock trades near 52-week low
Careteq (ASX: CTQ) raises A$2.2M via a two-tranche placement at A$0.005 per share to fund acquisitions, repay debt, and support working capital. Read the full analysis.
Polynovo stock falls as diabetes wound trial results spotlight NovoSorb promise
Polynovo (ASX: PNV) shares slipped 1.37% as NovoSorb diabetes wound trial results showed faster healing in large wounds. Can reimbursement shifts revive growth?
Metal Logic bets on modular smelting in Pilbara to reshape steel costs and sustainability
Metal Logic secures a Pilbara site to launch its modular low-emission smelting platform, aiming to cut steel costs, extend mine life, and boost green jobs.